Score contribution per author:
α: calibrated so average coauthorship-adjusted count equals average raw count
We study the demand responses of the drug copayment threshold in Finland using detailed prescription drug purchase data. The analysis reveals that the average drug costs increase discontinuously by 17% at the threshold above which out‐of‐pocket drug costs decrease substantially. Our results suggest an average price elasticity of −0.17, which indicates evident moral hazard costs. Approximately 80% of the overall effect is due to individuals buying drugs in larger quantities rather than purchasing higher‐priced drugs. The heterogeneity analysis suggests that the responses are largest for drug categories taken on an as‐needed rather than a regular basis.